Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-4.47%
↑ 27% above average
Average (5y)
-6.13%
Historical baseline
Range
High:-0.63%
Low:-14.01%
CAGR
+47.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -4.47% | +68.1% |
| 2023 | -14.01% | -15.4% |
| 2022 | -12.14% | -168.8% |
| 2021 | -4.52% | -349.6% |
| 2020 | -1.00% | -58.7% |
| 2019 | -0.63% | - |